The Oncosearch | Oncotarget

Suppression of B-Raf(V600E) cancers by MAPK hyper-activation Research Paper

Rawan Atiq, Rachel Hertz, Sophia Eldad, Elia Smeir, Jacob Bar-Tana

Published Mar 4, 2016 · Vol. 7, No. 14 · pp. 18694-18704

microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13 Research Paper

Han Han, Yuxing Chen, Li Cheng, Edward V. Prochownik, Youjun Li

Published Feb 24, 2016 · Vol. 7, No. 13 · pp. 16409-16419

miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells Research Paper

Elisabetta Crippa, Marco Folini, Marzia Pennati, Nadia Zaffaroni, Marco A. Pierotti, Manuela Gariboldi

Published Feb 23, 2016 · Vol. 7, No. 14 · pp. 18594-18604

Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA Research Paper

Aishwarya Subramanian, Adrian Andronache, Yao-Cheng Li, Mark Wade

Published Feb 21, 2016 · Vol. 7, No. 13 · pp. 15986-16002

A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA⁺ oral cancers Priority Research Paper

Kosuke Yamaguchi, Ramiro Iglesias-BartolomÃ©, Zhiyong Wang, Juan Luis Callejas-Valera, Panomwat Amornphimoltham, Alfredo A. Molinolo, Ezra E. Cohen, Joseph A. Califano, Scott M. Lippman, Ji Luo, J. Silvio Gutkind

Published Feb 13, 2016 · Vol. 7, No. 10 · pp. 10696-10709

CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells Research Paper

Shu-Ling Fu, Chun-Cheng Lin, Ming-Ling Hsu, Sheng-Hung Liu, Yu-Chuen Huang, Yu-Jen Chen

Published Feb 11, 2016 · Vol. 7, No. 10 · pp. 11677-11686

Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation Research Paper

Nayoung Kim, Ahye Cho, Hideo Watanabe, Yoon-La Choi, Meraj Aziz, Michelle Kassner, Je-Gun Joung, Angela Kyung-Joo Park, Joshua M. Francis, Joon Seol Bae, Soo-min Ahn, Kyoung-Mee Kim, Joon Oh Park, Woong-Yang Park, Myung-Ju Ahn, Keunchil Park, Jaehyung Koo, Hongwei Holly Yin, Jeonghee Cho

Published Feb 11, 2016 · Vol. 7, No. 12 · pp. 13797-13809

Improving the clinical impact of biomaterials in cancer immunotherapy Review

Joshua M. Gammon, Neil M. Dold, Christopher M. Jewell

Published Feb 10, 2016 · Vol. 7, No. 13 · pp. 15421-15443

Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor Research Paper

Ivan Casaburi, Grazia Maria Cesario, Ada DonÃ, Pietro Rizza, Saveria Aquila, Paola Avena, Marilena Lanzino, Michele Pellegrino, Adele Vivacqua, Paola Tucci, Catia Morelli, Sebastiano AndÃ², Diego Sisci

Published Feb 5, 2016 · Vol. 7, No. 11 · pp. 12651-12661

Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations Research Paper

Yi Sun, Wei Zhang, Yunqin Chen, Qin Ma, Jia Wei, Qi Liu

Published Jan 25, 2016 · Vol. 7, No. 8 · pp. 9404-9419

Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens Priority Research Paper

Shelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, Nouar Qutob, Jamie K. Teer, Nilly Shimony, Jacob Schachter, Steven A. Rosenberg, Michal J. Besser, Arie Admon, Yardena Samuels

Published Jan 20, 2016 · Vol. 7, No. 5 · pp. 5110-5117

PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response Research Paper

Stephanie Wurster, Fabian Hennes, Ann C. Parplys, Jasna I. Seelbach, Wael Y. Mansour, Alexandra Zielinski, Cordula Petersen, Till S. Clauditz, Adrian MÃ¼nscher, Anna A. Friedl, Kerstin Borgmann

Published Jan 19, 2016 · Vol. 7, No. 9 · pp. 9732-9741

A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers Research Paper

Sandra Hocke, Yang Guo, Albert Job, Michael Orth, Andreas Ziesch, Kirsten Lauber, Enrico N. De Toni, Thomas M. Gress, Andreas Herbst, Burkhard GÃ¶ke, Eike Gallmeier

Published Jan 9, 2016 · Vol. 7, No. 6 · pp. 7080-7095

Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells Research Paper

Yun-Ru Chen, Brittany Tsou, Shuya Hu, Huimin Ma, Xiyong Liu, Yun Yen, David K. Ann

Published Dec 9, 2015 · Vol. 7, No. 2 · pp. 1984-1999

Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection Research Paper

Pengfei Jiang, Wangqi Du, Yirong Xiong, Yan Lv, Juan Feng, Shanli Zhu, Xiangyang Xue, Shao Chen, Lifang Zhang

Published Dec 9, 2015 · Vol. 6, No. 41 · pp. 43281-43292

Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4 Research Paper

Lili Tian, Dachuan Shen, Xiaodong Li, Xiu Shan, Xiaoqi Wang, Qiu Yan, Jiwei Liu

Published Dec 2, 2015 · Vol. 7, No. 2 · pp. 1619-1632

A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model Research Paper

Yuh-Pyng Sher, Su-I Lin, I-Hua Chen, Hsin-Yu Liu, Chen-Yuan Lin, I-Ping Chiang, Steve Roffler, Hsin-Wei Chen, Shih-Jen Liu

Published Nov 26, 2015 · Vol. 7, No. 1 · pp. 671-683

Erratum: A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells Errata

Lei Qiu, Jie Li, Shichong Yu, Qianli Wang, Yinghua Li, Zhenlin Hu, Qiuye Wu, Zhongwu Guo, Junping Zhang

Published Nov 23, 2015 · Vol. 6, No. 37 · pp. 40385-40385

Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma Research Paper

Haohai Zhang, Chengpei Zhu, Yi Zhao, Ming Li, Liangcai Wu, Xiaobo Yang, Xueshuai Wan, Anqiang Wang, Michael Q. Zhang, Xinting Sang, Haitao Zhao

Published Oct 26, 2015 · Vol. 6, No. 41 · pp. 43770-43778

Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma Research Paper

Norihiko Tokuzen, Koh-ichi Nakashiro, Hiroshi Tanaka, Kazuki Iwamoto, Hiroyuki Hamakawa

Published Oct 19, 2015 · Vol. 7, No. 3 · pp. 2343-2353

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Suppression of B-Raf(V600E) cancers by MAPK hyper-activation Research Paper

microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13 Research Paper

miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells Research Paper

Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA Research Paper

A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA⁺ oral cancers Priority Research Paper

CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells Research Paper

Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation Research Paper

Improving the clinical impact of biomaterials in cancer immunotherapy Review

Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor Research Paper

Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations Research Paper

Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens Priority Research Paper

PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response Research Paper

A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers Research Paper

Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells Research Paper

Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection Research Paper

Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4 Research Paper

A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model Research Paper

Erratum: A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells Errata

Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma Research Paper

Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Suppression of B-Raf(V600E) cancers by MAPK hyper-activation Research Paper

microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13 Research Paper

miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells Research Paper

Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA Research Paper

A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers Priority Research Paper

CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells Research Paper

Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation Research Paper

Improving the clinical impact of biomaterials in cancer immunotherapy Review

Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor Research Paper

Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations Research Paper

Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens Priority Research Paper

PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response Research Paper

A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers Research Paper

Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells Research Paper

Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection Research Paper

Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4 Research Paper

A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model Research Paper

Erratum: A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells Errata

Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma Research Paper

Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma Research Paper

A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA⁺ oral cancers Priority Research Paper